Pillar · Biotech Investing
Biotech Due Diligence Checklist: How to Evaluate a Drug Pipeline and Probability of Approval
Most biotech investors skip due diligence and pay the price. This step-by-step checklist walks you through everything yo...
Start here
Pillar · Clinical Readouts
How to Read Biotech Clinical Trial Data: Phase 1, 2, 3 Results Explained for Investors
Clinical trial data is the single most important factor in biotech investing, but most investors struggle to read it. Th...
FDA & PDUFA Calendar
Setback for Galera Therapeutics in Pursuit of Cancer Treatment
In the realm of biopharmaceutical innovation, the pursuit of groundbreaking cancer therapies often presents a challenging journey. Galera Therapeutics, a pionee...
FDA & PDUFA Calendar
The Decline of SAVA Stock: Unpacking Cassava Sciences' Current Challenges
Investors have been closely monitoring Cassava Sciences' (SAVA) stock, as it experienced a significant downturn recently. This plunge in stock value is primaril...
Biotech Investing
Neurology Investing Strategies: How to Leverage FDA Catalysts for Maximum Alpha
The neurology sector presents some of biotech’s most explosive opportunities. These are driven by high-risk, high-reward clinical events in Alzheimer’s, Parkins...
Biotech Investing
Systemic Biotech Investing: Emerging Catalysts and Investor Takeaways
Systemic and miscellaneous biotech areas cover rare or multi organ conditions with unique catalysts. Explore benchmarks, case studies, and investor strategies i...
Biotech Investing
Immunology Biotech Investing: Key Catalysts and Investor Insights
Immunology biotech stocks often move sharply on pivotal data from immune system targeting therapies. Explore benchmarks, case studies, and investor strategies....
Biotech Investing
Oncology Biotech Investing: Key FDA Catalysts and Market Outlook
Oncology biotech stocks often deliver the largest market moves in biotech investing. Explore benchmarks, case studies, and strategies for navigating this high s...
Biotech Investing
Infectious Diseases Biotech Investing: Key Catalysts and Investor Strategy
Infectious disease biotech stocks often surge on pivotal trial outcomes for vaccines and antivirals. Explore benchmarks, case studies, and investor strategies....
Biotech Investing
Psychiatry Biotech Investing: Key Catalysts and Market Dynamics
Psychiatry biotech stocks often surge or collapse based on pivotal trial outcomes in mental health. Explore benchmarks, case studies, and investor insights....
Biotech Investing
ENT Biotech Investing: Key Catalysts and Investor Outlook
ENT biotech stocks often move on catalysts tied to hearing, airway, and sinus outcomes. Explore benchmarks, case studies, and investor strategies in this space....